Evidence map›Paper›PMID 39682085›Full record

ArticleCancers2024

Masked Image Modeling Meets Self-Distillation: A Transformer-Based Prostate Gland Segmentation Framework for Pathology Slides.

Haoyue Zhang, Sushant Patkar, Rosina Lis, Maria J Merino, Peter A Pinto, Peter L Choyke, Baris Turkbey, Stephanie Harmon

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haoyue ZhangArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.ORCID 0000-0002-9412-7584
Sushant PatkarArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.
Rosina LisArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.
Maria J MerinoTranslational Surgical Pathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Peter L ChoykeArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.ORCID 0000-0003-1086-8826
Baris TurkbeyArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.
Stephanie HarmonArtificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, Bethesda, MD 20814, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detailed evaluation of prostate cancer glands is an essential yet labor-intensive step in grading prostate cancer. Gland segmentation can serve as a valuable preliminary step for machine-learning-based downstream tasks, such as Gleason grading, patient classification, cancer biomarker building, and survival analysis. Despite its importance, there is currently a lack of a reliable gland segmentation model for prostate cancer. Without accurate gland segmentation, researchers rely on cell-level or human-annotated regions of interest for pathomic and deep feature extraction. This approach is sub-optimal, as the extracted features are not explicitly tailored to gland information. Although foundational segmentation models have gained a lot of interest, we demonstrated the limitations of this approach. This work proposes a prostate gland segmentation framework that utilizes a dual-path Swin Transformer UNet structure and leverages Masked Image Modeling for large-scale self-supervised pretaining. A tumor-guided self-distillation step further fused the binary tumor labels of each patch to the encoder to ensure the encoders are suitable for the gland segmentation step. We united heterogeneous data sources for self-supervised training, including biopsy and surgical specimens, to reflect the diversity of benign and cancerous pathology features. We evaluated the segmentation performance on two publicly available prostate cancer datasets. We achieved state-of-the-art segmentation performance with a test mDice of 0.947 on the PANDA dataset and a test mDice of 0.664 on the SICAPv2 dataset.

Indexed as

Deep Learningdigital pathologygland segmentationprostate cancerwhole slide image

Identifiers

PMID39682085
PMCPMC11640496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.